Table of Contents
Table 5-44: LaGrange
Table 5-46: LaPorte
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2000 | 1996 - 2000 | 2000 | 1996 - 2000 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 1,284 | 603.6 | 5,964 | 571.6 | 658 | 324.8 | 2,955 | 297.7 |
| Esophagus | 29 | 13.3 | 101 | 9.4 | 18 | 8.4** | 97 | 9.0 |
| Stomach | 22 | 11.1 | 135 | 13.4 | 18 | 9.5** | 91 | 9.2 |
| Colon excluding Rectum | 101 | 49.9 | 508 | 51.6 | 73 | 36.6 | 289 | 30.2 |
| Rectum and Rectosigmoid Junction | 49 | 22.9 | 247 | 24.0 | 9 | 4.5** | 41 | 4.0 |
| Liver | 21 | 9.3 | 53 | 4.8 | 14 | 6.7** | 66 | 6.4 |
| Pancreas | 23 | 11.0 | 133 | 13.3 | 33 | 16.0 | 162 | 16.5 |
| Lung and Bronchus | 236 | 110.9 | 1,054 | 100.2 | 197 | 95.4 | 933 | 90.7 |
| Melanoma of the Skin | 22 | 10.4 | 89 | 8.5 | 9 | 4.3** | 22 | 2.2 |
| Prostate | 399 | 187.9 | 1,785 | 170.6 | 69 | 37.8 | 339 | 38.7 |
| Urinary Bladder | 76 | 36.4 | 383 | 37.6 | 15 | 8.4** | 75 | 8.2 |
| Kidney and Renal Pelvis | 42 | 20.1 | 194 | 18.3 | 19 | 9.6** | 83 | 8.3 |
| Brain and Other Nervous System | 12 | 5.2** | 65 | 5.7 | 12 | 5.8** | 48 | 4.4 |
| Non-Hodgkin Lymphoma | 48 | 22.5 | 224 | 20.9 | 33 | 15.5 | 128 | 12.5 |
| Myeloma | 23 | 10.3 | 76 | 7.1 | 14 | 6.8** | 58 | 5.8 |
| Leukemia | 34 | 15.3 | 165 | 16.0 | 24 | 11.7 | 122 | 12.6 |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2000 | 1996 - 2000 | 2000 | 1996 - 2000 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 1,169 | 423.8 | 5,520 | 405.0 | 522 | 183.7 | 2,678 | 191.5 |
| Colon excluding Rectum | 112 | 38.7 | 571 | 40.4 | 43 | 14.6 | 274 | 19.3 |
| Rectum and Rectosigmoid Junction | 25 | 8.7 | 167 | 11.9 | 9 | 3.0** | 44 | 3.1 |
| Liver | 5 | 1.8** | 20 | 1.4 | 5 | 1.8** | 31 | 2.2 |
| Pancreas | 32 | 11.2 | 143 | 10.1 | 30 | 10.5 | 155 | 10.9 |
| Lung and Bronchus | 163 | 57.8 | 723 | 52.2 | 132 | 46.5 | 638 | 45.5 |
| Melanoma of the Skin | 16 | 6.1** | 79 | 5.9 | * | # | 21 | 1.5 |
| Breast | 351 | 129.6 | 1,688 | 125.8 | 95 | 34.0 | 500 | 36.8 |
| Cervix Uteri | 29 | 11.4 | 152 | 11.9 | 11 | 4.0** | 54 | 4.1 |
| Corpus Uteri | 72 | 26.7 | 332 | 24.7 | 8 | 2.8** | 36 | 2.5 |
| Ovary | 40 | 14.9 | 185 | 13.9 | 28 | 10.2 | 120 | 8.7 |
| Urinary Bladder | 29 | 10.0 | 131 | 9.4 | 6 | 2.0** | 43 | 3.0 |
| Kidney and Renal Pelvis | 31 | 11.1 | 131 | 9.7 | 8 | 3.1** | 36 | 2.6 |
| Brain and Other Nervous System | 14 | 5.3** | 69 | 5.1 | * | # | 41 | 2.9 |
| Non-Hodgkin Lymphoma | 47 | 17.1 | 212 | 15.4 | 15 | 5.3** | 75 | 5.3 |
| Myeloma | 14 | 4.8** | 69 | 5.0 | 9 | 3.1** | 46 | 3.3 |
| Leukemia | 30 | 10.6 | 129 | 9.5 | 21 | 7.3 | 81 | 5.8 |
Rates are per 100,000; Age-adjusted, 2000 U.S. Standard Million.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, October 2004
Table of Contents
Table 5-44: LaGrange
Table 5-46: LaPorte
